Clinical Trial Update: Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase II clinical trial update reporting the completion of a study evaluating PulmoBind for molecular imaging in pulmonary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• PulmoBind (DFH-12)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED